Trial NCT00068770

View at ClinicalTrials.gov 
Org. Study IDs: NABTT-2100 CDR0000328117
Secondary IDs: JHOC-NABTT-2100 NABTT-2100 U01CA062475

Last trial update was posted on 2015-03-18

MeSH Interventions

Celecoxib

MeSH Conditions

Central Nervous System Neoplasms Nervous System Neoplasms

Other Conditions

Brain and Central Nervous System Tumors

Stopping Reasons

EORTC trail showed TMZ & RT conferred significant survivial in this population

Limitations And Caveats

Study ended early when results from another study became available documenting Temozolomide (TMZ) and radiation improved survival, we felt it was unethical to continue this study, our study did not include TMZ.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID